Cardinal, GE Broaden Imaging Agent Access
March 18, 2008 - Cardinal Health and GE Healthcare penned a deal to broaden the availability of GE Healthcare's Myoview (Tetrofosmin) cardiac imaging agent through Cardinal Health's network of specialized nuclear pharmacies, giving Cardinal Health's customers greater access to Myoview, a myocardial perfusion imaging technetium agent used in the diagnosis and treatment of heart disease.
"With this agreement, Myoview will over time become the flagship branded cardiac imaging agent offered through Cardinal Health's nuclear pharmacies," said John Rademacher, president, nuclear and specialty pharmacy services for Cardinal Health. "Our commitment to the nuclear pharmacy business runs deep, and partnering with GE Healthcare to provide broader access to their product portfolio illustrates the unique way Cardinal Health can bring service and value to our customers and the nuclear medicine community."
Cardinal Health operates the largest radiopharmacy network in the United States with more than 150 nuclear pharmacy locations. It is also the largest employer of nuclear pharmacists in the world. The size of its network allows Cardinal Health to reach 85 percent of all U.S. hospitals within three hours and provide service and clinical expertise to the nuclear medicine community.
For more information: www.cardinalhealth.com and www.gehealthcare.com